These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36505810)

  • 1. Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis.
    Li Q; Chang Z; Wang T; Liu B; Wang X; Ge XY; Yang T; Liu Q; Wang W
    Front Oncol; 2022; 12():989080. PubMed ID: 36505810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion chemotherapy following simultaneous metallic stent placement and iodine-125 seed strands for advanced cholangiocarcinoma causing malignant obstructive jaundice: a propensity score matching study.
    Wu JZ; Li CL; Shi HB; Liu S; Yang W; Zhou WZ
    Jpn J Radiol; 2022 Apr; 40(4):396-403. PubMed ID: 34727330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 6. [Introduction of an interdisciplinary tumor board leads to improvement of treatment outcome of cholangiocarcinoma (bile duct cancer)].
    Juratli MA; Hofmann K; Balaban Ü; El Youzouri H; Pession U; Heise M; Mekicar J; Schreckenbach T; Trojan J; Waidmann O; Walter D; Vogl T; Eichler K; Wild P; Schulze F; Brandts C; Bechstein WO; Schnitzbauer AA; Mönch C
    Chirurg; 2020 Aug; 91(8):650-661. PubMed ID: 31932971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The combination of YAP/TAZ predicts the clinical prognosis in patients with cholangiocarcinoma after radical resection].
    Liu Y; Wu Y; Ouyang YS; He JJ; Shen LL; Qi H; Cao F; Chen SG
    Zhonghua Nei Ke Za Zhi; 2021 Jul; 60(7):637-643. PubMed ID: 34619841
    [No Abstract]   [Full Text] [Related]  

  • 8. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study.
    Wang L; Deng M; Ke Q; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y
    Cancer Med; 2020 Apr; 9(8):2674-2685. PubMed ID: 32072774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.
    Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS
    BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of postoperative adjuvant chemotherapy for intrahepatic cholangiocarcinoma patients undergoing R1 and R2 resections.
    Bhudhisawasdi V; Talabnin C; Pugkhem A; Khuntikeo N; Seow OT; Chur-in S; Pairojkul C; Wongkham S
    Asian Pac J Cancer Prev; 2012; 13 Suppl():169-74. PubMed ID: 23480760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
    Zhang G; Chen BW; Yang XB; Wang HY; Yang X; Xie FC; Chen XQ; Yu LX; Shi J; Lu YY; Zhao HT
    World J Gastroenterol; 2022 Nov; 28(41):5968-5981. PubMed ID: 36405111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent bile duct resection versus concomitant thrombectomy for hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis.
    Feng JK; Chen ZH; Sun JX; Wu JY; Guo WX; Shi J; Wei YG; Zhou JY; Zhang ZB; Yan ML; Cheng SQ
    Ann Transl Med; 2021 Mar; 9(6):457. PubMed ID: 33850854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
    Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
    Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein.
    Saikawa S; Kaji K; Nishimura N; Seki K; Sato S; Nakanishi K; Kitagawa K; Kawaratani H; Kitade M; Moriya K; Namisaki T; Mitoro A; Yoshiji H
    Cancer Lett; 2018 Oct; 434():120-129. PubMed ID: 30031758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
    Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
    J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study.
    Wang WQ; Li J; Liang BY; Lv X; Zhu RH; Wang JL; Huang ZY; Yang SH; Zhang EL
    Front Oncol; 2022; 12():980736. PubMed ID: 36059669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity Score Matching Analysis of the Effect of Payer Status on the Survival of Colon Cancer Patients.
    Shi L; Suh W; Kavanaugh MM; Mills G; Thayer S; Shi R
    Cureus; 2021 Jun; 13(6):e15748. PubMed ID: 34285854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.